Literature DB >> 27070999

Investigation of the Structure-Activity Relationships of Aza-A-Ring Indenoisoquinoline Topoisomerase I Poisons.

Daniel E Beck1, P V Narasimha Reddy1, Wei Lv1, Monica Abdelmalak2, Gabrielle S Tender2, Sophia Lopez2, Keli Agama2, Christophe Marchand2, Yves Pommier2, Mark Cushman1.   

Abstract

Several indenoisoquinolines have shown promise as anticancer agents in clinical trials. Incorporation of a nitrogen atom into the indenoisoquinoline scaffold offers the possibility of favorably modulating ligand-binding site interactions, physicochemical properties, and biological activities. Four series of aza-A-ring indenoisoquinolines were synthesized in which the nitrogen atom was systematically rotated through positions 1, 2, 3, and 4. The resulting compounds were tested to establish the optimal nitrogen position for topoisomerase IB (Top1) enzyme poisoning activity and cytotoxicity to human cancer cells. The 4-aza compounds were the most likely to yield derivatives with high Top1 inhibitory activity. However, the relationship between structure and cytotoxicity was more complicated since the potency was influenced strongly by the side chains on the lactam nitrogen. The most cytotoxic azaindenoisoquinolines 45 and 46 had nitrogen in the 2- or 3-positions and a 3'-dimethylaminopropyl side chain, and they had MGM GI50 values that were slightly better than the corresponding indenoisoquinoline 64.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27070999      PMCID: PMC5317104          DOI: 10.1021/acs.jmedchem.6b00003

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  39 in total

1.  The mechanism of topoisomerase I poisoning by a camptothecin analog.

Authors:  Bart L Staker; Kathryn Hjerrild; Michael D Feese; Craig A Behnke; Alex B Burgin; Lance Stewart
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-08       Impact factor: 11.205

2.  An ab initio quantum mechanics calculation that correlates with ligand orientation and DNA cleavage site selectivity in camptothecin-DNA-topoisomerase I ternary cleavage complexes.

Authors:  Xiangshu Xiao; Mark Cushman
Journal:  J Am Chem Soc       Date:  2005-07-20       Impact factor: 15.419

Review 3.  The NCI60 human tumour cell line anticancer drug screen.

Authors:  Robert H Shoemaker
Journal:  Nat Rev Cancer       Date:  2006-10       Impact factor: 60.716

Review 4.  Topoisomerase I inhibitors: camptothecins and beyond.

Authors:  Yves Pommier
Journal:  Nat Rev Cancer       Date:  2006-10       Impact factor: 60.716

5.  Synthesis and evaluation of indenoisoquinoline topoisomerase I inhibitors substituted with nitrogen heterocycles.

Authors:  Muthukaman Nagarajan; Andrew Morrell; Alexandra Ioanoviciu; Smitha Antony; Glenda Kohlhagen; Keli Agama; Melinda Hollingshead; Yves Pommier; Mark Cushman
Journal:  J Med Chem       Date:  2006-10-19       Impact factor: 7.446

6.  On the binding of indeno[1,2-c]isoquinolines in the DNA-topoisomerase I cleavage complex.

Authors:  Xiangshu Xiao; Smitha Antony; Yves Pommier; Mark Cushman
Journal:  J Med Chem       Date:  2005-05-05       Impact factor: 7.446

7.  Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I.

Authors:  Y H Hsiang; R Hertzberg; S Hecht; L F Liu
Journal:  J Biol Chem       Date:  1985-11-25       Impact factor: 5.157

8.  Nitrated indenoisoquinolines as topoisomerase I inhibitors: a systematic study and optimization.

Authors:  Andrew Morrell; Michael Placzek; Seth Parmley; Smitha Antony; Thomas S Dexheimer; Yves Pommier; Mark Cushman
Journal:  J Med Chem       Date:  2007-08-15       Impact factor: 7.446

9.  Synthesis and biological evaluation of new carbohydrate-substituted indenoisoquinoline topoisomerase I inhibitors and improved syntheses of the experimental anticancer agents indotecan (LMP400) and indimitecan (LMP776).

Authors:  Daniel E Beck; Keli Agama; Christophe Marchand; Adel Chergui; Yves Pommier; Mark Cushman
Journal:  J Med Chem       Date:  2014-02-11       Impact factor: 7.446

10.  Design, synthesis, and biological evaluation of O-2-modified indenoisoquinolines as dual topoisomerase I-tyrosyl-DNA phosphodiesterase I inhibitors.

Authors:  Peng-Cheng Lv; Keli Agama; Christophe Marchand; Yves Pommier; Mark Cushman
Journal:  J Med Chem       Date:  2014-05-06       Impact factor: 7.446

View more
  3 in total

1.  Synthesis of diverse spiro-imidazo pyridine-indene derivatives via acid-promoted annulation reaction of bindone and heterocyclic ketene aminals.

Authors:  Shima Nasri; Mohammad Bayat; Fatemeh Rostami Miankooshki
Journal:  Sci Rep       Date:  2022-07-22       Impact factor: 4.996

2.  Pd(II) Complexes with Pyridine Ligands: Substituent Effects on the NMR Data, Crystal Structures, and Catalytic Activity.

Authors:  Gracjan Kurpik; Anna Walczak; Mateusz Gołdyn; Jack Harrowfield; Artur R Stefankiewicz
Journal:  Inorg Chem       Date:  2022-08-19       Impact factor: 5.436

3.  Design, Synthesis, and Molecular Docking Study of New Tyrosyl-DNA Phosphodiesterase 1 (TDP1) Inhibitors Combining Resin Acids and Adamantane Moieties.

Authors:  Kseniya Kovaleva; Olga Yarovaya; Konstantin Ponomarev; Sergey Cheresiz; Amirhossein Azimirad; Irina Chernyshova; Alexandra Zakharenko; Vasily Konev; Tatiana Khlebnikova; Evgenii Mozhaytsev; Evgenii Suslov; Dmitry Nilov; Vytas Švedas; Andrey Pokrovsky; Olga Lavrik; Nariman Salakhutdinov
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.